Cargando…
LAT-1 and GLUT-1 Carrier Expression and Its Prognostic Value in Gastroenteropancreatic Neuroendocrine Tumors
SIMPLE SUMMARY: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) represent about 70% of all NETs; however, improvement in their outcomes has yet to be achieved. Here, we aimed to analyze the role of metabolic players such as the amino acid transporter 1 (LAT-1) and glucose transporter 1 (GLUT...
Autores principales: | Sampedro-Núñez, Miguel, Bouthelier, Antonio, Serrano-Somavilla, Ana, Martínez-Hernández, Rebeca, Adrados, Magdalena, Martín-Pérez, Elena, Muñoz de Nova, José Luis, Cameselle-Teijeiro, José Manuel, Blanco-Carrera, Concepción, Cabezas-Agricola, José Manuel, Díaz, José Ángel, García-Centeno, Rogelio, Aragones, Julian, Marazuela, Mónica |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7602091/ https://www.ncbi.nlm.nih.gov/pubmed/33066332 http://dx.doi.org/10.3390/cancers12102968 |
Ejemplares similares
-
Analysis of expression of the PD-1/PD-L1 immune checkpoint system and its prognostic impact in gastroenteropancreatic neuroendocrine tumors
por: Sampedro-Núñez, Miguel, et al.
Publicado: (2018) -
Neuroendocrine neoplasms: a brief overview emphasizing gastroenteropancreatic tumors
por: Lopes, José Manuel
Publicado: (2017) -
Aggressiveness of the tall cell variant of papillary thyroid carcinoma is independent of the tumor size and patient age
por: Villar-Taibo, Rocío, et al.
Publicado: (2017) -
Primary high-grade calcitonin-negative neuroendocrine carcinoma of the thyroid: a very rare cancer
por: Chorny, Joseph A, et al.
Publicado: (2018) -
Evaluation of (177)Lu-Dotatate treatment in patients with metastatic neuroendocrine tumors and prognostic factors
por: Abou Jokh Casas, Estephany, et al.
Publicado: (2020)